Posted on March 14, 2019 in: Member News
Zainab Alsamarae, Pharm.D.
St Joseph Mercy Hospital
Over 13 percent of Americans suffer from migraines and of these individuals, more than 90 percent miss work during a migraine attack. To date, there are a number of preventative treatment options for patients with migraines. Many preventative treatment options aid to reduce migraine attack frequency, quantity of migraines, or severity of each migraine. In order for patients to meet criteria for prophylactic pharmacotherapy, they must demonstrate at least two migraines a month with effects lasting at least three days or endorse uncommon migraine conditions such as a prolonged aura.1,2
Migraine Research. https://migraine.com/migraine-statistics/. Migraine Research Foundation. 2019.
Modi S. MD, Lowder D. PharmD. Medications for Migraine Prophylaxis. American Family Physician. https://www.aafp.org/afp/2006/0101/p72.html. 2006 Jan 1;73(1):72-78.
Moawad H MD. Therapies for Migraine Prophylaxis. Neurology Times. https://www.neurologytimes.com/headache-and-migraine/therapies-migraine-prophylaxis. 2018.
Aimovig Package Insert. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761077s000lbl.pdf. 2018.
Silberstein S.D., Holland S, et al. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults. http://n.neurology.org/content/78/17/1337.full. 2012; 78 (17).